Heartseed219A東証グロース医薬品FY ending Oct 2024, non-consolidated, J-GAAP
Heartseed brought in ¥873.6M in revenue.
It lost about ¥119 for every ¥100 of sales at the operating level.
Revenue changed +153.4% from the prior year.
FY ending Oct 2023 → FY ending Oct 2024
FY ending Oct 2023 → FY ending Oct 2024
For every ¥100 Heartseed sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書－第9期(2023/11/01－2024/10/31)
Extracted from XBRL: 35 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.